ASRNL 📈 ASR Nederland - Overview
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0011872643
ASRNL: Insurance, Pensions, Mortgages, Asset Management
ASR Nederland NV is a multifaceted financial services provider, offering a wide range of products including insurance, pensions, and mortgages to individuals, self-employed professionals, and companies. The company's operations are divided into five distinct segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. This diversified structure enables ASR Nederland NV to cater to various customer needs, from health and life insurance to financial planning and asset management. The Non-Life segment, for instance, provides insurance products such as road traffic, fire, and third-party liability, while the Life segment offers pension, funeral expense, and occupational disability insurance products.
The company's product portfolio is further complemented by its financial intermediary services, which facilitate transactions and provide expert advice to clients. Additionally, ASR Nederland NV engages in real estate development, leveraging its expertise to create value in the property market. As an asset manager, the company also provides investment solutions to third-party clients, demonstrating its capabilities in managing diverse asset classes. The various brands under the ASR Nederland NV umbrella, including Loyalis, Ditzo, Europeesche Verzekeringen, a.s.r. asset management, Ardanta, and a.s.r., serve as conduits for the company's products and services, each targeting specific customer segments and needs.
With a rich history dating back to 1720, ASR Nederland NV has evolved significantly over the years, adapting to changing market conditions and customer requirements. Formerly known as Fortis Verzekeringen Nederland NV, the company underwent a rebranding in 2008, emerging as ASR Nederland NV. Headquartered in Utrecht, the Netherlands, ASR Nederland NV continues to operate as a major player in the country's financial services sector, with its common stock listed under the ISIN code NL0011872643 and classified under the Multi-line Insurance sub-industry. The company's website, accessible at https://www.asrnl.com, provides further information on its products, services, and mission.
Additional Sources for ASRNL Stock
ASRNL Stock Overview
Market Cap in USD | 10,038m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
ASRNL Stock Ratings
Growth 5y | 69.3% |
Fundamental | 48.6% |
Dividend | 77.8% |
Rel. Strength Industry | -61.6 |
Analysts | - |
Fair Price Momentum | 43.96 EUR |
Fair Price DCF | 308.46 EUR |
ASRNL Dividends
Dividend Yield 12m | 6.68% |
Yield on Cost 5y | 11.63% |
Annual Growth 5y | 9.36% |
Payout Consistency | 89.6% |
ASRNL Growth Ratios
Growth Correlation 3m | 63.7% |
Growth Correlation 12m | 74.7% |
Growth Correlation 5y | 93.6% |
CAGR 5y | 11.47% |
CAGR/Mean DD 5y | 1.28 |
Sharpe Ratio 12m | 0.33 |
Alpha | -11.96 |
Beta | 0.77 |
Volatility | 21.19% |
Current Volume | 1156.6k |
Average Volume 20d | 483.9k |
As of December 21, 2024, the stock is trading at EUR 44.48 with a total of 1,156,576 shares traded.
Over the past week, the price has changed by -1.59%, over one month by -1.31%, over three months by +1.53% and over the past year by +11.00%.
Partly, yes. Based on ValueRay Fundamental Analyses, ASR Nederland (AS:ASRNL) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.57 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASRNL as of December 2024 is 43.96. This means that ASRNL is currently overvalued and has a potential downside of -1.17%.
ASR Nederland has no consensus analysts rating.
According to ValueRays Forecast Model, ASRNL ASR Nederland will be worth about 52.1 in December 2025. The stock is currently trading at 44.48. This means that the stock has a potential upside of +17.04%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 53 | 19.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 52.1 | 17% |